Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer
Jeeyun Ahn, Won Ryang Wee, Jin Hak Lee, Joon Young Hyon
Korean J Ophthalmol. 2011;25(5):355-357.   Published online 2011 Sep 20     DOI: https://doi.org/10.3341/kjo.2011.25.5.355
Citations to this article as recorded by Crossref logo
Ocular surface toxicities associated with modern anticancer therapies
Rafael Boucher, Oscar Haigh, Emmanuel Barreau, Stéphane Champiat, Olivier Lambotte, Clovis Adam, Marc Labetoulle, Antoine Rousseau
Survey of Ophthalmology.2024; 69(2): 198.     CrossRef
Ocular Surface Side Effects of Novel Anticancer Drugs
Livio Vitiello, Filippo Lixi, Giulia Coco, Giuseppe Giannaccare
Cancers.2024; 16(2): 344.     CrossRef
Drug-induced corneal deposits: an up-to-date review
Jean-Yves Sahyoun, Saama Sabeti, Marie-Claude Robert
BMJ Open Ophthalmology.2022; 7(1): e000943.     CrossRef
Ocular Toxicity of Targeted Anticancer Agents
Blake H. Fortes, Prashant D. Tailor, Lauren A. Dalvin
Drugs.2021; 81(7): 771.     CrossRef
The impact of anticancer drugs on the ocular surface
Jeremy Chung Bo Chiang, Ilyanoon Zahari, Maria Markoulli, Arun V. Krishnan, Susanna B. Park, Annalese Semmler, David Goldstein, Katie Edwards
The Ocular Surface.2020; 18(3): 403.     CrossRef
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, Francesca Leonardi, Davide Londei, Marta Padovan, Mario Caccese, Giulia Marchione, Silvia Bini, Vittorina Zagonel, Luisa Frizziero
Therapeutic Advances in Medical Oncology.2020; 12: 175883592090754.     CrossRef
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors
Eunhae Shin, Dong Hui Lim, Jisang Han, Do-Hyun Nam, Keunchil Park, Myung-Ju Ahn, Won Ki Kang, Jeeyun Lee, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Hyun Ae Jung, Tae-Young Chung
BMC Ophthalmology.2020;[Epub]     CrossRef
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, Davide Londei, Marta Padovan, Giulia Marchione, Mario Caccese, Giulia Midena, Vittorina Zagonel, Luisa Frizziero
Frontiers in Oncology.2020;[Epub]     CrossRef
Confocal Microscopy Observation of Cornea Verticillata After Vandetanib Therapy for Medullary Thyroid Carcinoma
Pedro Arriola-Villalobos, Blanca Benito-Pascual, David Díaz-Valle, José M. Benítez-del-Castillo
Cornea.2018; 37(6): 789.     CrossRef
Corneal Toxicity Induced by ABT-414 Therapy for Glioblastoma Multiforme: A Case Report
Hamoon Eshraghi, Dimosthenis Mantopoulos, Leejee H. Suh, Francisco Zaldana, Howard F. Fine
Case Reports in Ophthalmology.2018; 9(3): 479.     CrossRef
Drug-induced corneal epithelial changes
Michael B. Raizman, Pedram Hamrah, Edward J. Holland, Terry Kim, Francis S. Mah, Christopher J. Rapuano, Roger G. Ulrich
Survey of Ophthalmology.2017; 62(3): 286.     CrossRef
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
Elizabeth R. Kessler, S. Gail Eckhardt, Todd M. Pitts, Erica L. Bradshaw-Pierce, Cindy L. O’byrant, Wells A. Messersmith, Sujatha Nallapreddy, Colin Weekes, Jennifer Spratlin, Christopher H. Lieu, Madeleine A. Kane, Sarah Eppers, Elizabeth Freas, Stephen
Investigational New Drugs.2016; 34(2): 176.     CrossRef
In VivoConfocal Microscopic Findings of Corneal Tissue in Amiodarone-Induced Vortex Keratopathy
Jae Jung Lee, Beom Seok Choi, Young Min Park, Jong Soo Lee
Journal of the Korean Ophthalmological Society.2015; 56(1): 127.     CrossRef
Vortex Keratopathy Presumed Secondary to AZD9291
Puey Ling Chia, Thomas John
Journal of Thoracic Oncology.2015; 10(12): 1807.     CrossRef
Cordarone keratopathyand Fabry disease: Differential diagnosis, treatment
Sergey Yur'yevich Astakhov, Natal'ya Viktorovna Tkachenko, Sanasar Surikovich Papanyan
Ophthalmology Reports.2015; 8(2): 71.     CrossRef
Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review
Olivier Huillard, Silvin Bakalian, Christine Levy, Laurence Desjardins, Livia Lumbroso-Le Rouic, Simona Pop, Marie-Paule Sablin, Christophe Le Tourneau
European Journal of Cancer.2014; 50(3): 638.     CrossRef
Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment
Nanjun Liu, Elizabeth A. Tengstrand, Lisa Chourb, Frank Y. Hsieh
Toxicology and Applied Pharmacology.2014; 279(3): 467.     CrossRef
Ocular toxicity from systemically administered xenobiotics
Mitan R Gokulgandhi, Aswani Dutt Vadlapudi, Ashim K Mitra
Expert Opinion on Drug Metabolism & Toxicology.2012; 8(10): 1277.     CrossRef